People News

Share this article:

Following its acquisition of Genentech, Roche has announced that Pascal Soriot, currently head of Roche's commercial pharmaceutical operations, will become Genentech's CEO, effective May 1, 2009. Soriot succeeds Arthur Levinson, chairman and CEO of Genentech since 1995. Levinson will retain his position as chairman.

 

Alnara Pharmaceuticals, a pharma manufacturer focused on the treatment of metabolic diseases, announced the promotion of Robert Gallotto to chief business officer. Gallotto was previously SVP, operations and corporate development.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media